Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score: 3

ash.confex.com

Oral and Poster Abstracts 623. Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Poster III Clinical Trials, Biological, Lymphomas, Non-Hodgkin Lymphoma, Bispecific Antibody Therapy, Clinical Research, B Cell Lymphoma, Diseases, Indolent Lymphoma, Therapies, Lymphoid Malignancies Kim M Linton, MBChB, PhD1*,...

  • 123456 Profile photo of Madelyn

    Very early data from a Phase1/2 of Subcutaneous Ecoritamab in combination with rituximab and lenolidomide (perhaps call it E=R^2?) in patients with relapsed or refractory follicular lymphoma was presented. Only 5 patients were evaluable for efficacy at the abstract data cut-off with a 100% response rate.